They concluded that in some pathologic conditions including fibrosis in age related macular degeneration (ARMD), retinal ischemia, retinal neuropathy, and fibrovascular membrane contraction in diabetic retinopathy, ROCK inhibitors may be effective beyond VEGF inhibition [17]. The gene discussed is VEGFA; the disease is age-related macular degeneration.